Biotechblog

New patent for Novartis drug PLUVICTO

May 15, 2024 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for PLUVICTO Pluvicto is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting…
Source

New patent for Msd Merck drug RECARBRIO

May 15, 2024 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for RECARBRIO Recarbrio is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There is one…
Source

1
2
3
…
4,049
Next →